MusclePharm Receives Accolades in Brazil
13 May 2014 - 10:01PM
Marketwired
MusclePharm Receives Accolades in Brazil
DENVER, CO--(Marketwired - May 13, 2014) - MusclePharm
Corporation (OTCQB: MSLP), a scientifically driven,
performance-lifestyle sports nutrition company today announced it
has received the following honors in Brazil:
- MusclePharm's Assault™ was named the best pre-workout product
by fitness magazine Premio Revista Suplementacao. The
magazine also named MusclePharm® as the best supplement brand.
- MusclePharm Assault was the recipient of a Top 30 Award from
Corpo Perfeito, the largest online provider of nutritional
supplements in Brazil. Corpo Perfeito also honored the company
for its sales performance.
"We are honored to receive such accolades, which highlight the
quality of our products and their growing adoption in a country
known for its athleticism," said Brad Pyatt, chief executive
officer of MusclePharm. "In a relatively short period of time, we
have established MusclePharm as a leading brand in Brazil.
"As we continue to build MusclePharm's presence in this
fast-growing market, we are encouraged by our brand awareness on
the heels of the Arnold Classic in Rio and as the country prepares
for the World Cup and the 2016 Olympics," Pyatt added.
About MusclePharm MusclePharm® is a scientifically driven,
performance-lifestyle company that currently develops,
manufactures, markets and distributes branded nutritional
supplements. The company offers a complete range of powders,
capsules, tablets and gels. Its portfolio of recognized brands,
including MusclePharm® Hybrid and Core Series, Arnold
Schwarzenegger Series™ and FitMiss®, are marketed and sold in more
than 110 countries and available in over 35,000 retail outlets
globally. These clinically-proven and scientific nutritional
supplements are developed through a six-stage research process
utilizing the expertise of leading nutritional scientists, doctors
and universities. MusclePharm is the innovator of the sports
nutrition industry. For more information, visit
www.musclepharm.com
Follow the company at http://www.facebook.com/MusclePharm and
www.Twitter.com/MusclePharm
To sign up to receive MusclePharm news via email, please visit
http://ir.musclepharmcorp.com/email-alerts
Forward-Looking Statements This release contains forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities and Exchange
Act of 1934, as amended. Statements that are not a description of
historical facts constitute forward-looking statements and may
often, but not always, be identified by the use of such words as
"expects", "anticipates", "intends", "estimates", "plans",
"potential", "possible", "probable", "believes", "seeks", "may",
"will", "should", "could" or the negative of such terms or other
similar expressions. Actual results may differ materially from
those set forth in this release due to the risks and uncertainties
inherent in the Company's business. More detailed information about
the Company and the risk factors that may affect the realization of
forward-looking statements is set forth in the Company's Annual
Report on Form 10-K for the fiscal year ended December 31, 2013,
the Company's Quarter Reports on Form 10-Q and other filings
submitted by the Company to the SEC, copies of which may be
obtained from the SEC's website at www.sec.gov. Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof. All
forward-looking statements are qualified in their entirety by this
cautionary statement and the Company undertakes no obligation to
revise or update this release to reflect events or circumstances
after the date hereof.
Contacts: Matt Sheldon/Evan Pondel PondelWilkinson Inc. (310)
279-5980 investors@musclepharm.com
Muscle Pharm (CE) (USOTC:MSLP)
Historical Stock Chart
From Apr 2024 to May 2024
Muscle Pharm (CE) (USOTC:MSLP)
Historical Stock Chart
From May 2023 to May 2024